デフォルト表紙
市場調査レポート
商品コード
1089756

バイオ医薬品受託製造の世界市場:製品別、由来別、契約タイプ別、サービス別、事業規模別、治療用途別、地域別の予測(2027年まで) - COVID-19の累積的影響

Biopharmaceuticals Contract Manufacturing Market Research Report by Product, Source, Contract Type, Service, Scale of Operation, Therapeutic Applications, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 206 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
バイオ医薬品受託製造の世界市場:製品別、由来別、契約タイプ別、サービス別、事業規模別、治療用途別、地域別の予測(2027年まで) - COVID-19の累積的影響
出版日: 2022年06月15日
発行: 360iResearch LLP
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオ医薬品受託製造の市場規模は、2027年までに679億3,000万米ドルに達し、CAGRで15.92%の成長が予測されています。

当レポートでは、世界のバイオ医薬品受託製造市場について調査分析し、市場の機会や課題、促進要因・抑制要因、COVID-19の累積的影響、製品別、由来別、契約タイプ別、サービス別、事業規模別、治療用途別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 バイオ医薬品受託製造市場:製品別

  • 生物製剤
  • バイオシミラー

第7章 バイオ医薬品受託製造市場:由来別

  • 哺乳類
  • 微生物/非哺乳類ベースの生物製剤

第8章 バイオ医薬品受託製造市場:契約タイプ別

  • 有効成分(API)
  • 充填・仕上げ

第9章 バイオ医薬品受託製造市場:サービス別

  • 分析・品質管理研究
  • 充填・仕上げ作業
  • 包装
  • プロセス開発

第10章 バイオ医薬品受託製造市場:事業規模別

  • 臨床
  • 商業

第11章 バイオ医薬品受託製造市場:治療用途別

  • 心血管疾患
  • 感染症
  • 神経学
  • 腫瘍学
  • 眼科
  • 呼吸器疾患

第12章 南北アメリカのバイオ医薬品受託製造市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋地域のバイオ医薬品受託製造市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第14章 欧州・中東・アフリカのバイオ医薬品受託製造市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第16章 企業のユーザビリティプロファイル

  • AbbVie, Inc.
  • AGC Biologics
  • Ajinomoto Co. Inc.
  • Binex Co., Ltd.
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Cambrex Corporation
  • FUJIFILM Diosynth Biotechnologies U.S.A. Inc
  • General Electric Co.
  • INCOG BioPharma Services
  • Inno Bio Ventures Sdn Bhd
  • JRS Pharma
  • Lonza AG
  • Merck KGaA
  • Pressure BioSciences
  • ProBioGen AG
  • Rentschler Biotechnologie GmbH
  • Samsung Biologics Co. Ltd.
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co. Ltd.
  • WuXi Biologics, Inc.

第17章 付録

図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: DYNAMICS
  • FIGURE 2. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2027
  • FIGURE 5. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD BILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, 2019-2027 (USD BILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2021 VS 2027 (%)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2021 VS 2027 (USD BILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2027
  • FIGURE 12. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, 2019-2027 (USD BILLION)
  • FIGURE 13. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 14. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, 2019-2027 (USD BILLION)
  • FIGURE 15. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 16. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2021 VS 2027 (%)
  • FIGURE 17. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2021 VS 2027 (USD BILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2027
  • FIGURE 19. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), 2019-2027 (USD BILLION)
  • FIGURE 20. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 21. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, 2019-2027 (USD BILLION)
  • FIGURE 22. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 23. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (%)
  • FIGURE 24. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (USD BILLION)
  • FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2027
  • FIGURE 26. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, 2019-2027 (USD BILLION)
  • FIGURE 27. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 28. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, 2019-2027 (USD BILLION)
  • FIGURE 29. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 30. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, 2019-2027 (USD BILLION)
  • FIGURE 31. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 32. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, 2019-2027 (USD BILLION)
  • FIGURE 33. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 34. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2021 VS 2027 (%)
  • FIGURE 35. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2027
  • FIGURE 37. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, 2019-2027 (USD BILLION)
  • FIGURE 38. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 39. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, 2019-2027 (USD BILLION)
  • FIGURE 40. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 41. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2021 VS 2027 (%)
  • FIGURE 42. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2021 VS 2027 (USD BILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2027
  • FIGURE 44. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 45. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 46. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, 2019-2027 (USD BILLION)
  • FIGURE 47. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 48. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD BILLION)
  • FIGURE 49. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 50. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 51. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 52. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 53. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 54. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, 2019-2027 (USD BILLION)
  • FIGURE 55. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 56. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 57. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 58. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 59. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 60. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 61. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 62. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 63. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 64. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 65. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 66. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 67. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 68. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 69. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 70. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 71. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 72. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 73. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 74. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 75. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 76. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 77. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 78. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 79. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 80. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 81. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 82. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 83. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 84. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 85. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 86. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 87. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 88. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 6. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 7. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 10. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 12. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SOURCE, 2019-2027 (USD BILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 16. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 17. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 18. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 21. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 22. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 23. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 24. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL-BASED BIOLOGICS/NON-MAMMALIA, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT TYPE, 2019-2027 (USD BILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2019-2027 (USD BILLION)
  • TABLE 27. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 28. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY STATE, 2019-2027 (USD BILLION)
  • TABLE 29. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 30. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API), BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 32. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 33. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL-AND-FINISHED, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 38. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 39. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 40. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 41. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL & QUALITY CONTROL STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 43. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 44. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 45. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 46. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY FILL & FINISH OPERATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 48. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 49. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 50. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 53. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 54. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 55. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY SCALE OF OPERATION, 2019-2027 (USD BILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 59. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 60. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 64. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 65. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 66. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2019-2027 (USD BILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 70. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 71. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 72. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 75. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 76. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 77. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 80. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 81. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 82. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 85. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 86. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 87. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 90. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 91. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 92. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 95. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 96. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 97. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 99. AMERICAS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 100. ARGENTINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 101. BRAZIL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 102. CANADA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 103. MEXICO BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 104. UNITED STATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 105. ASIA-PACIFIC BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 106. AUSTRALIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 107. CHINA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 108. INDIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 109. INDONESIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 110. JAPAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 111. MALAYSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 112. PHILIPPINES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 113. SINGAPORE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 114. SOUTH KOREA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 115. TAIWAN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 116. THAILAND BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 118. FRANCE BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 119. GERMANY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 120. ITALY BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 121. NETHERLANDS BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 122. QATAR BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 123. RUSSIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 124. SAUDI ARABIA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 125. SOUTH AFRICA BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 126. SPAIN BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 127. UNITED ARAB EMIRATES BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 128. UNITED KINGDOM BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 129. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: SCORES
  • TABLE 130. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
  • TABLE 131. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
  • TABLE 132. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: RANKING
  • TABLE 133. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 134. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
  • TABLE 135. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 136. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 137. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
  • TABLE 138. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 139. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
目次
Product Code: MRR-8C74ADFC160E

The Global Biopharmaceuticals Contract Manufacturing Market grew USD 67.93 billion by 2027, at a CAGR of 15.92%.

The Global Biopharmaceuticals Contract Manufacturing Market size was estimated at USD 27.99 billion in 2021 and expected to reach USD 32.37 billion in 2022, and is projected to grow at a CAGR 15.92% to reach USD 67.93 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biopharmaceuticals Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Biologics and Biosimilar.

Based on Source, the market was studied across Mammalian and Microbial-Based Biologics/Non-Mammalia.

Based on Contract Type, the market was studied across Active Pharmaceutical Ingredient (API) and Fill-and-Finished.

Based on Service, the market was studied across Analytical & Quality Control Studies, Fill & Finish Operations, Packaging, and Process Development.

Based on Scale of Operation, the market was studied across Clinical and Commercial.

Based on Therapeutic Applications, the market was studied across Cardiovascular Diseases, Infectious Disease, Neurology, Oncology, Ophthalmology, and Respiratory Disorder.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biopharmaceuticals Contract Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceuticals Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceuticals Contract Manufacturing Market, including AbbVie, Inc., AGC Biologics, Ajinomoto Co. Inc., Binex Co., Ltd., Boehringer Ingelheim Biopharmaceuticals GmbH, Cambrex Corporation, FUJIFILM Diosynth Biotechnologies U.S.A. Inc, General Electric Co., INCOG BioPharma Services, Inno Bio Ventures Sdn Bhd, JRS Pharma, Lonza AG, Merck KGaA, Pressure BioSciences, ProBioGen AG, Rentschler Biotechnologie GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific, Inc., Toyobo Co. Ltd., and WuXi Biologics, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biopharmaceuticals Contract Manufacturing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceuticals Contract Manufacturing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceuticals Contract Manufacturing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biopharmaceuticals Contract Manufacturing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biopharmaceuticals Contract Manufacturing Market?
  • 6. What is the market share of the leading vendors in the Global Biopharmaceuticals Contract Manufacturing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceuticals Contract Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising outsourcing by biopharmaceutical companies
      • 5.1.1.2. Increasing Number of CMOs and Rising Investments in Advanced Manufacturing Technologies
      • 5.1.1.3. Growing demand for biologics globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of setting up a production facility for biopharmaceuticals
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in biopharmaceutical R&D and manufacturing
      • 5.1.3.2. Growing focus on speciality drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for CMOs
  • 5.2. Cumulative Impact of COVID-19

6. Biopharmaceuticals Contract Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Biologics
  • 6.3. Biosimilar

7. Biopharmaceuticals Contract Manufacturing Market, by Source

  • 7.1. Introduction
  • 7.2. Mammalian
  • 7.3. Microbial-Based Biologics/Non-Mammalia

8. Biopharmaceuticals Contract Manufacturing Market, by Contract Type

  • 8.1. Introduction
  • 8.2. Active Pharmaceutical Ingredient (API)
  • 8.3. Fill-and-Finished

9. Biopharmaceuticals Contract Manufacturing Market, by Service

  • 9.1. Introduction
  • 9.2. Analytical & Quality Control Studies
  • 9.3. Fill & Finish Operations
  • 9.4. Packaging
  • 9.5. Process Development

10. Biopharmaceuticals Contract Manufacturing Market, by Scale of Operation

  • 10.1. Introduction
  • 10.2. Clinical
  • 10.3. Commercial

11. Biopharmaceuticals Contract Manufacturing Market, by Therapeutic Applications

  • 11.1. Introduction
  • 11.2. Cardiovascular Diseases
  • 11.3. Infectious Disease
  • 11.4. Neurology
  • 11.5. Oncology
  • 11.6. Ophthalmology
  • 11.7. Respiratory Disorder

12. Americas Biopharmaceuticals Contract Manufacturing Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Biopharmaceuticals Contract Manufacturing Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand

14. Europe, Middle East & Africa Biopharmaceuticals Contract Manufacturing Market

  • 14.1. Introduction
  • 14.2. France
  • 14.3. Germany
  • 14.4. Italy
  • 14.5. Netherlands
  • 14.6. Qatar
  • 14.7. Russia
  • 14.8. Saudi Arabia
  • 14.9. South Africa
  • 14.10. Spain
  • 14.11. United Arab Emirates
  • 14.12. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
    • 15.1.1. Quadrants
    • 15.1.2. Business Strategy
    • 15.1.3. Product Satisfaction
  • 15.2. Market Ranking Analysis
  • 15.3. Market Share Analysis, By Key Player
  • 15.4. Competitive Scenario
    • 15.4.1. Merger & Acquisition
    • 15.4.2. Agreement, Collaboration, & Partnership
    • 15.4.3. New Product Launch & Enhancement
    • 15.4.4. Investment & Funding
    • 15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles

  • 16.1. AbbVie, Inc.
  • 16.2. AGC Biologics
  • 16.3. Ajinomoto Co. Inc.
  • 16.4. Binex Co., Ltd.
  • 16.5. Boehringer Ingelheim Biopharmaceuticals GmbH
  • 16.6. Cambrex Corporation
  • 16.7. FUJIFILM Diosynth Biotechnologies U.S.A. Inc
  • 16.8. General Electric Co.
  • 16.9. INCOG BioPharma Services
  • 16.10. Inno Bio Ventures Sdn Bhd
  • 16.11. JRS Pharma
  • 16.12. Lonza AG
  • 16.13. Merck KGaA
  • 16.14. Pressure BioSciences
  • 16.15. ProBioGen AG
  • 16.16. Rentschler Biotechnologie GmbH
  • 16.17. Samsung Biologics Co. Ltd.
  • 16.18. Thermo Fisher Scientific, Inc.
  • 16.19. Toyobo Co. Ltd.
  • 16.20. WuXi Biologics, Inc.

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing